The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.
In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...
Disclaimer: This Working Paper should not be reported as representing the views of the IMF.The views expressed in this Working Paper are those of the author(s) and do not necessarily represent those ...
This course is available on the MSc in Applied Social Data Science, MSc in Data Science, MSc in Econometrics and Mathematical Economics, MSc in Health Data Science, MSc in Operations Research & ...